Niklas Hedberg is both chair of EUnetHTA Executive Board (a branch of the European Commission) and chief pharmacist at the Swedish Dental and Pharmaceutical Benefits Agency (TLV). EUnetHTA aids European Union member states in conducting Health Technology Assessments (HTAs). Hedberg outlines the function EUnetHTA plays in the European Commission along with current and future HTA trends.
Almost everyone agrees that we can come further in a joint approach to HTA. It is about defining the space between traditional regulatory work and the start of the health economic evaluation.
